FDA 483 - Marine Polymer Technologies - July 06, 2026

Marine Polymer Technologies, a medical device manufacturer in Topsfield, MA, was inspected by the FDA, revealing significant deficiencies in their quality management system. The inspection cited failures in documenting nonconforming product procedures, handling customer complaints, controlling changes to processes, and maintaining adequate personnel training records. These issues indicate a systemic lack of adherence to established quality control practices.